Join to View Full Profile
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center530 East 74th StreetNew York, NY 10021
Dr. Ghione is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Paola Ghione is a hematologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from University of Torino Faculty of Medicine and has been in practice 9 years. She specializes in Diffuse large B-cell lymphoma, follicular lymphoma, marginal zone lymphoma, mantle cell lymphoma, cutaneous lymphomas, hodgkin's lymphoma, T cell lymphoma.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2020
University of Torino Faculty of MedicineClass of 2011
Certifications & Licensure
FL State Medical License 2023 - Present
CT State Medical License 2025 - 2026
NY State Medical License 2020 - 2026
Clinical Trials
- Measuring Cell-Free DNA (cfDNA) Levels in People With Follicular Lymphoma Start of enrollment: 2020 Jul 08
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Lessons learned from experience of phosphatidylinositol 3-kinase inhibitors in chronic lymphocytic leukemia and lymphoma.Paola Ghione, Pier Luigi Zinzani, Jennifer R Brown
Haematologica. 2025-12-01 - Skin Response to Mogamulizumab in Patients With Mycosis Fungoides and Sezary Syndrome: A Retrospective, Real World Cohort.Rachel E Christensen, Robert Stuver, Stephen Dusza, Zachary D Epstein-Peterson, Paola Ghione
Clinical Lymphoma, Myeloma & Leukemia. 2025-12-01 - Mutational and copy number analysis at diagnosis and relapse of mantle cell lymphoma.Erel Joffe, Manik Uppal, Serena Zheng, Kurt S Bantilan, Connie Batlevi
Haematologica. 2025-11-27
Abstracts/Posters
- Final Results of a Phase II Biomarker-Driven Study of Ruxolitinib in Relapsed and Refractory T-Cell LymphomaPaola Ghione, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Central Nervous System Prophylaxis with High-Dose Intravenous Methotrexate or Intrathecal Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma and High-Risk of ...Paola Ghione, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Contemporary Outcomes in HTLV-1-Associated Adult T-Cell Leukemia/Lymphoma: Single-Institution ExperiencePaola Ghione, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3,546 women prospectively followed after receiving textured breast implants.ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
- Incidence of Delayed Seromas and Related Risk of Bia-ALCL in a Cohort of 3521 Breast Cancer Women with Textured Implants Prospectively Followed Long Term61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Press Mentions
BRCA Mutations Linked to Breast Implant Anaplastic Large Cell LymphomaJune 26th, 2025- BRCA Mutations Hike Risk of Rare Breast Implant-Associated LymphomaJune 17th, 2025
- Rewrite Hereditary Mutations in BRCA Genes Increase Risk of Rare Lymphoma Among Women with Breast Cancer Who Received Textured Breast Implants This News Headline for the Science Magazine PostJune 13th, 2025
Grant Support
- Impact of germline mutations on the development of breast-implant associated anaplastic large cell lymphoma (BIA-ALCL) in women with textured breast implantsSLOAN-KETTERING INST CAN RESEARCH2022–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
